prosaptide
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2003 (NCT00286377)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- c-Jun N-terminal kinase 1ACTIVATOR
MAPK8 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- prosaptide
- prosaptide
- prosaptide
- tx14(a)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00286377 | Phase 2 | Sep 1, 2003 | Neurologic AIDS Research Consortium, Savient Pharmaceuticals |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Neurologic AIDS Research Consortium | Academic/Hospital | 1 | 0 | 1 | 2003 |
| Savient Pharmaceuticals | For profit | 1 | 1 | 1 | 2003 |
2 organizations
Page 1 / 1